Parainfluenza virus 3 (PIV3) is a respiratory virus associated with severe childhood illnesses, particularly bronchiolitis and pneumonia. It is also known as human parainfluenza virus type 3 (HPIV3). PIV3 is a member of the Paramyxoviridae family, which includes other viruses such as measles, mumps, and respiratory syncytial virus (RSV). Despite its prevalence in the population, there is still much that is unknown about PIV3 and the diseases it causes. In this article, we will discuss the epidemiology, transmission, diagnosis, treatment, and prevention of PIV3.
PIV3 is a common virus, with an estimated 20-40% of all childhood respiratory illnesses being caused by it. It is most commonly seen in young children, with the highest incidence occurring in children between the ages of 6 months and 2 years. PIV3 is more common in the winter months, with peak activity occurring in December and January. It is also more common in certain geographical areas, such as the southeastern United States and in lower-income countries.
PIV3 is spread through contact with respiratory secretions, such as saliva, mucus, or nasal secretions. It is also spread through contact with surfaces or objects that have been contaminated with the virus. PIV3 is highly contagious and can be spread through coughing and sneezing.
The diagnosis of PIV3 is usually made based on clinical symptoms. However, laboratory tests can be used to confirm the diagnosis. These tests include polymerase chain reaction (PCR) tests, virus isolation, and serology tests.
There is no specific treatment for PIV3. Treatment is mainly supportive, and may include oxygen therapy, hydration, and medications to reduce fever and relieve symptoms. In severe cases, hospitalization may be necessary.
The best way to prevent PIV3 is to practice good hygiene. This includes washing hands often with soap and water, avoiding contact with people who are sick, and avoiding sharing items such as cups and utensils. Vaccines are also available to prevent PIV3, but they are not routinely recommended.
Parainfluenza virus 3 is a common virus that is associated with severe childhood illnesses. It is spread through contact with respiratory secretions and contaminated objects. Diagnosis is usually based on clinical symptoms, but laboratory tests can be used to confirm the diagnosis. Treatment is mainly supportive, and prevention is best achieved through good hygiene practices. Vaccines are available, but are not routinely recommended.
1.
Electronic Sepsis Alerts; Reducing Plaques in Coronary Arteries
2.
Ivonescimab Tops Pembrolizumab in PD-L1-Positive, Advanced NSCLC
3.
Hereditary cancer has a rare and underreported cause.
4.
New imaging guidelines for head and neck cancers, a step toward practice change
5.
BMTs that are "half-matched" are effective in treating severe sickle cell disease.
1.
Oncolytic Adenoviruses Targeting PD-L1: Advancing Cancer Immunotherapy and Tumor Control
2.
Personalized Cancer Vaccines: The Next Frontier in Precision Oncology
3.
Essential Updates in Hematology in Daily Practice
4.
The Predictive Power of Theranostics in Palliative Neuroendocrine Tumor Management
5.
Importance of Early Detection in Oncology
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VII
2.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part I
3.
Current Scenario of Cancer- The Incidence of Cancer in Men
4.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part IV
5.
A New Era in Managing Cancer-Associated Thrombosis
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation